|
Definition of Enalapril
1. Noun. An ACE inhibitor (trade name Vasotec) that blocks the formation of angiotensin in the kidney and so results in vasodilation; administered after heart attacks.
Generic synonyms: Ace Inhibitor, Angiotensin-converting Enzyme Inhibitor
Language type: Trade Name
Definition of Enalapril
1. Noun. An angiotensin converting enzyme inhibitor used in the treatment of hypertension and some types of chronic heart failure. ¹
¹ Source: wiktionary.com
Definition of Enalapril
1. [n -S]
Medical Definition of Enalapril
1.
Lexicographical Neighbors of Enalapril
Literary usage of Enalapril
Below you will find example usage of this term as found in modern and/or classical literature:
1. A Lifelong Passion: Nicholas and Alexandra: Their Own Story by Andrei Maylunas (2005)
"II: Investigation of the potential role of enalapril In deaths with renal failure.
... The possibility that enalapril might damage renal function was ..."
2. 5th Report Of The Joint National Committee On Detection, Evaluation, And by DIANE Publishing Company (2004)
"Effect of enalapril on survival in patients with reduced left ventricular ejection
fractions and ... A comparison of enalapril with hydralazine- isosorbide ..."
3. Diabetes in America by Ronald Aubert (1996)
"Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effect of
enalapril in diabetic nephropathy. Br Med J 304:339-43, 1992 242. ..."
4. The Women's Health and Aging Study: Health and Social Characteristics of edited by Jack M. Guralnik, Linda P. Fried, Eleanor M. Simonsick, Judith D. Kasper, Mary E. Lafferty (1995)
"... of enalapril on mortality and the development of heart failure in asymptomatic
patients with reduced left ventricular ejection fractions. ..."
5. Mineral Tolerance of Animals by National Research Council (U. S.) (2005)
"... including causing nephropathy and peripheral nerve disorders, have not been
precisely defined. Arginine and enalapril prevent nephropathy caused by ..."
6. Norway by OECD (2005)
"Razzolini, T. (2004), "The Norwegian Market for Pharmaceuticals and the Non-Mandatory
Substitution Reform of 2001: The Case of enalapril", Department of ..."